TVG successfully completes DARPA-funded transmissible Lassa fever vaccine project

Lassa fever virus

Most emerging infectious diseases affecting humans in the last century originated in animal reservoirs and are defined as zoonotic. Lassa fever is a significant zoonotic disease threat to human health in eight West African countries with between an estimated 100,000 to 300,000 cases of disease each year, of which about 5,000 are fatal1. The reservoir […]

Successful Streptococcus suis vaccine project completion

TVG ECO Pig Image

TVG has completed a successful Anglo-Chinese project backed by the Department of Health and Social Care (DHSC), Innovate UK, and the Chinese Ministry of Science and Technology to develop a cross-protective candidate Streptococcus suis (S suis) vaccine against the most prevalent serotypes 2, 7 and 9. S suis is a major bacterial disease that reduces […]

TVG appoints a new Laboratory Manager

As TVG prepares for future growth a new position of Laboratory Manager has been created and we are delighted to announce that after an extensive recruitment campaign Angela Ward has been appointed to the role and will start work on 12th August. Angela has performed a similar role at the Marine Biology Association in Plymouth […]

TVG Chief Scientific Officer receives National Institute of Health Award

The Vaccine Group is proud to announce that Dr Michael Jarvis, TVG’s Chief Scientific Officer, has been recognised in the 2021 NIH Director’s Awards. Dr Jarvis will receive this award as a member of the NIAID RML Virology Lab and Veterinary Branch SARS-CoV-2 Research Team, nominated by the National Institute of Allergy and Infectious Diseases, […]

The Vaccine Group appoints GALVmed Chief Scientific Officer Jeremy Salt as Chief Executive Officer


The Vaccine Group (“TVG” or the “Company”) is pleased to announce the appointment of Dr Jeremy Salt as Chief Executive Officer. Jeremy has extensive experience in senior roles in animal healthcare across organisations in the commercial and not-for-profit sectors. He is joining TVG from GALVmed, a not-for-profit organisation that develops and makes available livestock vaccines, medicines and diagnostics […]